Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Ding

Showing results (421-430 of 453) with videos related to

Pageof 46
Sort By:
Journal of Medicinal Chemistry|January 3, 1997
Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivityG C Rovnyak, S Z Ahmed, C Z Ding, et al.
Clinical Genetics|April 21, 2018
Clinical and molecular insights into Glanzmann's thrombasthenia in ChinaL Zhou, M Jiang, H Shen, et al.
Gene Therapy|September 7, 2002
A gene therapy for cancer based on the angiogenesis inhibitor, vasostatinF Xiao, Y Wei, L Yang, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infectionYanbin Hu, Fei Sun, Qiang Yuan, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2024
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitorZhaobing Xu, Yingchun Liu, Baohui Song, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2013
Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenaseBenjamin P Fauber, Peter S Dragovich, Jinhua Chen, et al.
Oncogene|July 8, 2014
Autophagy mediates HIF2α degradation and suppresses renal tumorigenesisX-D Liu, J Yao, D N Tripathi, et al.
Oncogene|September 15, 2015
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinomaL Zhou, X-D Liu, M Sun, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolaseKarnail S Atwal, Saleem Ahmad, Charles Z Ding, et al.
Pageof 46

Showing results (421-430 of 453) with videos related to

Sort By:
Pageof 46
Journal of Medicinal Chemistry|January 3, 1997
Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivityG C Rovnyak, S Z Ahmed, C Z Ding, et al.
Clinical Genetics|April 21, 2018
Clinical and molecular insights into Glanzmann's thrombasthenia in ChinaL Zhou, M Jiang, H Shen, et al.
Gene Therapy|September 7, 2002
A gene therapy for cancer based on the angiogenesis inhibitor, vasostatinF Xiao, Y Wei, L Yang, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infectionYanbin Hu, Fei Sun, Qiang Yuan, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2024
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitorZhaobing Xu, Yingchun Liu, Baohui Song, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2013
Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenaseBenjamin P Fauber, Peter S Dragovich, Jinhua Chen, et al.
Oncogene|July 8, 2014
Autophagy mediates HIF2α degradation and suppresses renal tumorigenesisX-D Liu, J Yao, D N Tripathi, et al.
Oncogene|September 15, 2015
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinomaL Zhou, X-D Liu, M Sun, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolaseKarnail S Atwal, Saleem Ahmad, Charles Z Ding, et al.
Pageof 46